The effect of Parp1 ablation was neither mouse nor ES cell-specific, as silencing of PARP1 by short interfering RNA (siRNA) in human CAL51 and DLD1 tumour cells also caused resistance to BMN 673 and olaparib (Figure 3). This evidence concerns the gene PARP1 and neoplasm.